Enhancing safety and outcomes with the newer antithrombotic and antiplatelet agents.

Tcheng, J E

Enhancing safety and outcomes with the newer antithrombotic and antiplatelet agents. [electronic resource] - American heart journal Sep 1995 - 673-9 p. digital

Publication Type: Journal Article; Review

0002-8703

10.1016/0002-8703(95)90305-4 doi


Abciximab
Antibodies, Monoclonal--adverse effects
Clinical Trials as Topic
Eptifibatide
Fibrinolytic Agents--adverse effects
Humans
Immunoglobulin Fab Fragments--adverse effects
Peptides--adverse effects
Platelet Aggregation Inhibitors--adverse effects
Safety